rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Cipla Ltd.

500087 CIPLA Group (A)

22 Jul,15:29
1490.00
4.85 (0.33%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Cipla Ltd.

BUYSELL
68,963 1,485.15 1,506.75 - 1,470.05 1,581.70 - 1,028.00 120,332.41
NSE | BSE

Cipla Ltd.

CIPLA

22 Jul,15:55
1490.00
4.50 (0.30%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Cipla Ltd.

BUYSELL
1,328,847 1485.50 1,507.05 - 1,470.65 1,582.00 - 1,027.00 1,984,566,552.15

News for Cipla Ltd.

Cipla Faces Rs...
Cipla Faces Rs 773 Crore I-T Demand: Details - Business News
Cipla receives a Rs 773.44 crore demand notice from the income tax department for assessment years 2015-16 to 2022-23. The company plans to appeal the order.
Jul 16, 2024 16:40
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Orchid Pharma &...
Orchid Pharma & Cipla Partner for New Antibiotic in India
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...
Jun 28, 2024 19:42
Cipla Gets USFDA...
Cipla Gets USFDA Nod for Generic Lanreotide Injection
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.
May 22, 2024 12:13
Cipla Promoters...
Cipla Promoters Sell 2.53% Stake for Rs 2,750 Cr | News
Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...
May 15, 2024 19:25

More News for Cipla Ltd. »

(Rs. Crore)

Financial Results of Cipla Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales16,574.3415,790.6013,091.7913,900.5812,659.15
Operating profit4,484.153,792.583,366.473,721.562,707.29
Interest20.2527.0226.9345.0736.05
Gross profit5,534.564,222.354,006.243,906.773,564.09
EPS (Rs)50.5031.1436.6630.6128.75

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Cipla Ltd.

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia

News for Pharmaceuticals and health care

China FDI:...
China FDI: Short-Term Gains, Long-Term Risks - GTRI
GTRI warns that increasing Chinese FDI in India may offer short-term benefits but could undermine long-term economic security and strategic autonomy.
Jul 22, 2024 20:22
DMRC Partners...
DMRC Partners with Airtel Payments Bank for Digital Payments
Delhi Metro Rail Corporation (DMRC) has partnered with Airtel Payments Bank to offer digital payment solutions for commuters, including National Common Mobility Card (NCMC) transactions.
Jul 22, 2024 20:12
Nokia Achieves...
Nokia Achieves 1.2 Gbps 5G Speed in Airtel Trial
Nokia and Bharti Airtel achieve a record-breaking 1.2 Gbps download speed during a 5G trial in India using Nokia's Cloud RAN technology. This milestone highlights the potential of 5G for high-speed...
Jul 22, 2024 20:06
JNPA to Build...
JNPA to Build Agri-Commodity Facility at Port for Rs 285 Cr
Jawaharlal Nehru Port Authority (JNPA) will develop a Rs 285 crore agri-commodity processing and storage facility at the port to serve Maharashtra and other states. This initiative, a...
Jul 22, 2024 19:46
PE/VC Investment...
PE/VC Investment Surges 8% to $31.5 Billion in H1 2024
Private equity and venture capital investments in India rose 8% to USD 31.5 billion in the first half of 2024, driven by a surge in deal volume and large transactions, according to a report by IVCA...
Jul 22, 2024 19:28

More News »

Top News

China FDI:...
China FDI: Short-Term Gains, Long-Term Risks - GTRI
GTRI warns that increasing Chinese FDI in India may offer short-term benefits but could undermine long-term economic security and strategic autonomy.
Jul 22, 2024 20:22
Bengal Potato Traders Strike: Export Restrictions, Price Hikes
Potato traders in West Bengal are on indefinite strike, protesting against alleged harassment and restrictions on exports. The strike is expected to lead to higher potato prices.
Jul 22, 2024 20:17
DMRC Partners...
DMRC Partners with Airtel Payments Bank for Digital Payments
Delhi Metro Rail Corporation (DMRC) has partnered with Airtel Payments Bank to offer digital payment solutions for commuters, including National Common Mobility Card (NCMC) transactions.
Jul 22, 2024 20:12
India Needs Small...
India Needs Small Reforms For Growth: CEA
India's Chief Economic Advisor says the country needs smaller, more fundamental reforms to drive growth, focusing on government efficiency and infrastructure. The IMF has raised India's growth...
Jul 22, 2024 20:12
Banks Resist Short-Term Profits: Economic Survey 2023-24
The Economic Survey 2023-24 urges banks to resist pursuing short-term profits, emphasizing long-term stability and customer focus. It also highlights concerns about product misselling and calls for...
Jul 22, 2024 20:08

More Top News »

Report Card

PE Ratios
29.38
EPS (Rs.)
50.50
Sales (Rs. Cr)
4,036.66
Face Value (Rs.)
2
Net Profit Margin (%)
15.91
Last Bonus
3:2
Last Dividend(%)
650
Return on Average Equity
10.21

BSE Announcements from Cipla Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 3 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 4 day(s) ago

Compare 'Cipla Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am 50 year old retired person.I have fd of 2 cr...

Hi sir right now 22 I want to invest in MF around...

Hello sir, I am 23 years old, just graduated and...

I am 66, my annual income is 8 lacs. What are the...

Im 39, my husband 42 both working. 10L MF started...

Hi, I am employed in Maldives from last one year and...

More REDIFFGURUS

RediffGurus

Money question

Hello Sir, I am 29 yrs old, unmarried in hand salary...

Cipla Ltd. performance snapshot

If you had invested Rs.  in Cipla Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Cipla Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Cipla Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Cipla Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close